Clinical trial
A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day…
NCT00130169 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00130169 |
|---|---|
| Title | A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies |
| Official title | A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer, Malignant Tumors |
| Intervention type | Drug |
| Interventions | E7974 |
| Enrollment | 30 |
| Start date | Jan 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Aug 15, 2005 |
| Last update posted | Jul 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: